Early virological response is a predictor of treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center 'real-life' cohort

Steinebrunner N.; Sprinzl M. F.; Zimmermann T.; Woerns M. A.; Zimmerer T.; Galle P. R.; Stremmel W.; Eisenbach C.; Stein K.; Antoni C.; Schattenberg J. M.; Pathil A.

首页> 外文期刊>Journal of viral hepatitis. >Early virological response is a predictor of treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center 'real-life' cohort

【24h】

Early virological response is a predictor of treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center 'real-life' cohort

机译：早期病毒学应答是多中心“现实”队列中基于sofosbuvir的慢性丙型肝炎联合治疗中治疗应答的预测指标

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of viral hepatitis.》 |2015年第2期|共1页
作者
Steinebrunner N.; Sprinzl M. F.; Zimmermann T.; Woerns M. A.; Zimmerer T.; Galle P. R.; Stremmel W.; Eisenbach C.; Stein K.; Antoni C.; Schattenberg J. M.; Pathil A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort [J] . Niels Steinebrunner, Martin F Sprinzl, Tim Zimmermann, BMC Gastroenterology . 2015,第1期

机译：早期病毒学应答可能在多中心“现实生活”队列中预测基于索非布韦的慢性丙型肝炎联合治疗的治疗反应
2. Results of sofosbuvir-based combination therapy for chronic hepatitis C cohort of Indian patients in real-life clinical practice [J] . Sood Ajit, Midha Vandana, Mahajan Ramit, Journal of gastroenterology and hepatology . 2017,第4期

机译：基于Sofosbuvir的慢性丙型肝炎联合疗法治疗现实临床实践中的慢性丙型肝炎组合疗法
3. Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study. [J] . Noritomo Shimada, Hidenori Toyoda, Akihito Tsubota, Journal of gastroenterology . 2014,第11期

机译：一项多中心研究显示，基线因子和非常早期的病毒反应（第1周）可预测基于telaprevir的三联联合疗法对日本基因型1b慢性丙型肝炎患者的持续病毒学应答。
4. Predictability of Sustained Virological Response (SVR) in Patients with HCV/HIV Co-infection During Combination Therapy With Peginterferon Alfa-2A (40KD) (PEGASYS~R) Plus Ribavirin (COPEGUS~R) in the APRICOT Trial [C] . M. Rodriguez Torres, F.J. Torriani, E. Lissen International AIDS Conference . 2004

机译：HCV / HIV与Peginterferon Alfa-2a（40KD）（Pegasys〜R）加上利韦韦林（Copegus〜R）在杏试验期间HCV / HIV CONOMENT患者持续病毒学反应（SVR）的可预测性
5. Patient Experience on Therapy for Hepatitis C Virus, The Impact of Successful Treatment on Liver Stiffness, and The Meaning of Sustained Virologic Response [D] . Nickerson, Jillian Elizabeth 2015

机译：乙型肝炎病毒治疗患者体验，成功治疗对肝硬化的影响，以及持续的病毒性反应的含义
6. Rapid Virological Response to Peginterferon Alfa and Ribavirin Treatment of Chronic Hepatitis C Predicts Sustained Virological Response and Relapse in Genotype 1 Patients [O] . Fred Poordad, Carmen Landaverde 2009

机译：对Peginterferon Alfa和利巴韦林的快速病毒学应答慢性丙型肝炎的治疗可预测持续的病毒学应答和基因1型患者复发
7. Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort [O] . Steinebrunner, Niels, Sprinzl, Martin F., Zimmermann, Tim, 2015

机译：早期病毒学应答可能在多中心“现实生活”队列中预测基于索非布韦的慢性丙型肝炎联合治疗的治疗反应

Early virological response is a predictor of treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center 'real-life' cohort

著录项

相似文献

相关主题

期刊订阅